Indivior

All Articles

Drugmaker Indivior saw its shares slump nearly 20 per cent this morning after the firm booked a loss for the fourth quarter on the back of falling prices for its flagship opioid treatment.

Drugmaker Indivior saw its shares slump nearly 20 per cent this morning after the firm booked a loss for the

February 13, 2020

Indivior soared on the markets this morning as it raised full-year guidance after its Suboxone lost less market share than

July 11, 2019

By Graeme Evans from interactive investor. The FTSE 100 outperformed mid-caps last tax year, but the top FTSE 350 performers

April 15, 2019

Shares in FTSE 250-listed drug company Indivior crashed 70 per cent this morning after it was hit with a US

April 10, 2019

British drugs firm Indivior has launched a copycat version of its opioid addiction drug Suboxone in the US, shortly after

February 20, 2019

Ftse-250 pharmaceuticals company Indivior said today its operating profit increased 51 per cent to $292m (£228m) in 2018. The company

February 14, 2019

Pharmaceutical company Indivior’s share price crashed 17 per cent this morning after a US court ruling opened the way for

February 5, 2019

Drug company Indivior has agreed to sell its rights related to the Sai Bo Song (buprenorphine, naloxone) tablet in China

February 4, 2019

Indivior shares jumped over 17 per cent today as the company decided to take on generic copies of its star

December 18, 2018

FTSE 250 pharma giant Indivior saw its share price plunge more than 10 per cent in early morning trading, after

November 21, 2018

  Shares in addiction treatment pharma firm Indivior took a eight per cent hit this morning after it said sales

September 27, 2018

Shares at Indivior crumbled during yesterday’s trade but recovered to be down only 2.4 per cent. The FTSE-listed company which

February 11, 2015

Content tagged with "Indivior"